SARS-CoV-2 omicron variant may evade host immune responses

A recent study has demonstrated that the omicron variant of severe acute respiratory syndrome coronavirus 2 has a higher ability to evade antibody-mediated neutralization than other variants of concern.

Frontiers Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies

SARS-CoV-2 learned the 'Alpha'bet of immune evasion

SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development - Ao - 2022 - MedComm - Wiley Online Library

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies - eBioMedicine

Omicron may be significantly better at evading vaccine-induced immunity, but less likely to cause severe disease

Immune response in COVID-19: what is next?

Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines

SARS-CoV-2 Omicron variant: recent progress and future perspectives

Frontiers Immune response induced by novel coronavirus infection

Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines - Araf - 2022 - Journal of Medical Virology - Wiley Online Library

The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity, Virology Journal

Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies - ScienceDirect